Multifocal intraocular lens (IOL) technology offers patients substantial be
nefits. The elimination of a presbyopic condition and restoration of normal
vision by simulating accommodation greatly enhances the quality of life fo
r most patients. The only multifocal IOL available for general use in the U
nited States is the AMO Array (Allergan Surgical Products, Irvine, CA). The
advantages of astigmatically neutral clear corneal cataract surgery have a
llowed for increased utilization of multifocal technology in both cataract
and clear lens replacement surgery. Careful attention to patient selection,
preoperative biometry, and lens power calculations, in addition to meticul
ous surgical technique, will allow surgeons to offer multifocal technology
to their patients with great success.